During the past decade, Carnegie Imaging for Women conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Carnegie Imaging for Women" #1 collaborator was "Columbia University" with 1 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 1 trials as a collaborator and "George Washington University" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Carnegie Imaging for Women" are "Aneuploidy" (1 trials), "Multiple Gestation; Maternal Care" (1 trials), "Pregnancy Complications" (1 trials), "Trisomy 13" (1 trials) and "Trisomy 18" (1 trials). Many other conditions were trialed in "Carnegie Imaging for Women" in a lesser frequency.

Most popular intervention types in "Carnegie Imaging for Women" are "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Blood Draw" (1 trials). Other intervention names were less common.

The vast majority of trials in "Carnegie Imaging for Women" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "Carnegie Imaging for Women". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Carnegie Imaging for Women, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Carnegie Imaging for Women, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".